Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04987138 · ClinicalTrials.gov registry record · NA

Safety and Effectiveness Study of the Zenflow Spring System

A NA study of BPH (Benign Prostatic Hyperplasia) and Lower Urinary Tract Symptoms (LUTS), sponsored by Zenflow.

Active
Registry status
NA
Development phase
279
Enrollment target
7
Study locations

NCT04987138 is a NA study of BPH (Benign Prostatic Hyperplasia) and Lower Urinary Tract Symptoms (LUTS) that is active but no longer recruiting, run by Zenflow. The registered enrollment target is 279 participants. The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04987138, a NA study of BPH (Benign Prostatic Hyperplasia) and Lower Urinary Tract Symptoms (LUTS), is active but no longer recruiting, sponsored by Zenflow.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
279 participants
Enrollment target
7
Study locations

Study Summary

Evaluate the safety and effectiveness of the Zenflow Spring System in relieving LUTS associated with BPH.

Interventions

  • DEVICE Sham Procedure
  • DEVICE Zenflow Spring System

Study Locations (7)

Texas

  • Midtown Urology Associates - Austin
  • Urology Austin, PLLC - Austin

California

  • American Institute of Research - Los Angeles

Illinois

  • Northshore University Health System - Glenview

Nevada

  • Sheldon Freedman, MD, LTD - Las Vegas

South Carolina

  • Carolina Urologic Research Associates - Myrtle Beach

Virginia

  • Urology of Virginia, PLLC - Virginia Beach

Trial Details

FieldValue
Enrollment Target 279 participants
Start Date 2021-09-30
Est. Completion 2026-06
Phase NA

Sponsor

Zenflow

2 total trials

What the Registry Record Tells You About NCT04987138

The ClinicalTrials.gov registry entry for NCT04987138 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 279 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zenflow, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with BPH (Benign Prostatic Hyperplasia) appearing as the primary indexed condition, and to 2 interventions - of which Sham Procedure is the first listed.

NCT04987138 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Texas, California, Illinois.

Frequently Asked Questions

What is clinical trial NCT04987138 about?

NCT04987138 is a clinical study titled "Safety and Effectiveness Study of the Zenflow Spring System". Evaluate the safety and effectiveness of the Zenflow Spring System in relieving LUTS associated with BPH.

What is the current status of trial NCT04987138?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 279 participants. The study started on 2021-09-30. Estimated completion is 2026-06.

What conditions does trial NCT04987138 study?

This clinical trial studies the following conditions: BPH (Benign Prostatic Hyperplasia), Lower Urinary Tract Symptoms (LUTS).

What interventions are being tested in trial NCT04987138?

The interventions under investigation include: Sham Procedure (DEVICE), Zenflow Spring System (DEVICE).

Who is sponsoring clinical trial NCT04987138?

This trial is sponsored by Zenflow, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04987138 being conducted?

This trial has 7 study locations across California, Illinois, Nevada, South Carolina, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for BPH (Benign Prostatic Hyperplasia)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.